LOS ANGELES—Aug. 15, 2022—The Celiac Disease Foundation, the nation’s leading patient advocacy organization for celiac disease, announced today that Amanda Halligan has been named Director of Marketing and Communications, effective immediately.

In this role, Halligan will lead the development and implementation of the Foundation’s strategic marketing and communications plan, manage media relations activities, and oversee public policy and advocacy program strategy.

“Amanda brings a wealth of professional and personal experience to this key leadership position,” said Marilyn G. Geller, Celiac Disease Foundation CEO. “She will be a vital part of strengthening our existing relationships and forging new connections for our organization in its next phase of growth. We’re excited to have her join our team.”

Halligan joins the Foundation with decades of experience working at the intersection of communications, policy, and advocacy on behalf of individuals and organizations in the public, private, and non-profit sectors. She has worked as a reporter, editor, speechwriter, spokesperson, and has served as a strategic advisor to several elected officials. As she serves the Foundation and its constituents, she is deeply motivated by her personal experience navigating a protracted celiac diagnosis and 17 years of gluten-free living.

About the Celiac Disease Foundation

Founded in 1990, the Celiac Disease Foundation is the nation’s leading patient advocacy organization dedicated to accelerating the diagnosis and treatment of celiac disease. Through strategic investments in research, advocacy, and education, the Celiac Disease Foundation seeks to improve the quality of life for the more than 3 million individuals in the United States affected by this chronic immune-mediated disease. Hosting the iCureCeliac® patient registry and offering robust patient recruitment services, the Celiac Disease Foundation targets patient candidates to speed enrollment and improve trial retention to drive discoveries that may lead to better treatments, and ultimately, a cure. For more information, please visit celiac.org.